首页> 外文OA文献 >Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study

【2h】

Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study

机译：DOTINURAD的临床疗效和安全性，一种新型选择性尿酸重吸收抑制剂，在日本高尿酸患者有或没有痛风的情况下：探索性，随机，多中心，双盲，安慰剂控制，并行组早期2研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Tatsuo Hosoya; Takafumi Sano; Tomomitsu Sasaki; Masahiko Fushimi; Tetsuo Ohashi;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study [J] . Hosoya Tatsuo, Sano Takafumi, Sasaki Tomomitsu, Clinical and experimental nephrology . 2020,第Suppla1期

机译：DOTINURAD的临床疗效和安全性，一种新型选择性尿酸重吸收抑制剂，在日本高尿酸患者有或没有痛风的情况下：探索性，随机，多中心，双盲，安慰剂控制，并行组早期2研究
2. Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study [J] . Hosoya Tatsuo, Sano Takafumi, Sasaki Tomomitsu, Clinical and experimental nephrology . 2020,第Suppla1期

机译：Dotinurad，一种新颖的选择性尿液重吸收抑制剂Dotinurad的临床疗效和安全性，在日本高尿动患者中或没有痛风的情况下：随机，多中心，双盲，安慰剂控制，并行组，确认期2研究
3. Clinical efficacy and safety of topiroxostat in Japanese male hyperuricemic patients with or without gout: an exploratory, phase 2a, multicentre, randomized, double-blind, placebo-controlled study [J] . Hosoya T., Sasaki T., Hashimoto H., Journal of Clinical Pharmacy and Therapeutics . 2016,第3期

机译：托吡司他在日本男性高尿酸血症患者中是否有痛风的临床疗效和安全性：探索性，2a期，多中心，随机，双盲，安慰剂对照研究
4. Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized double-blinded controlled phase 2b study [O] . Tatsuo Hosoya, Tomomitsu Sasaki, Tetsuo Ohashi -1

机译：托吡司他在有或没有痛风的日本高尿酸血症患者中的临床疗效和安全性：一项随机双盲对照2b期研究
5. Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: randomized, multicenter, double-blind, placebo-controlled, parallel-group, confirmatory phase 2 study [O] . Tatsuo Hosoya, Takafumi Sano, Tomomitsu Sasaki, 2019

机译：Dotinurad，一种新颖的选择性尿液重吸收抑制剂Dotinurad的临床疗效和安全性，在日本高尿动患者中或没有痛风的情况下：随机，多中心，双盲，安慰剂控制，并行组，确认期2研究

Clinical efficacy and safety of dotinurad, a novel selective urate reabsorption inhibitor, in Japanese hyperuricemic patients with or without gout: an exploratory, randomized, multicenter, double-blind, placebo-controlled, parallel-group early phase 2 study

著录项

引文网络

相似文献

相关主题

期刊订阅